Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
The Journal of Infectious Diseases|April 10, 2004
Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trialStephen L SacksCurrent Infectious Disease Reports|January 15, 2003
Therapeutic Options for Herpes Simplex InfectionsEugene Au, Stephen L. SacksHerpes : the Journal of the IHMF|December 10, 2002
Antivirals in the prevention of genital herpesEugene Au, Stephen L SacksExpert Opinion on Pharmacotherapy|December 2, 2004
Docosanol: a topical antiviral for herpes labialisDaniel T Leung, Stephen L SacksExpert Opinion on Pharmacotherapy|October 3, 2003
Current treatment options to prevent perinatal transmission of herpes simplex virusDaniel T Leung, Stephen L SacksJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 15, 2002
Development and validation of a plasma assay for acyclovir using high-performance capillary electrophoresis with sample stackingHung C Vo, Paul A Henning, Daniel T Leung, et al.Journal of Virological Methods|April 15, 2004
Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCRMadhu Singh, Annie Dicaire, Adil E Wakil, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2005
Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trialStephen L Sacks, Fred Y Aoki, Alain Y Martel, et al.Journal of Cutaneous Medicine and Surgery|June 3, 2005
Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trialsStephen K Tyring, Francisco Diaz-Mitoma, Stephen D Shafran, et al.American Journal of Obstetrics and Gynecology|March 14, 2003
A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean deliveryD Heather Watts, Zane A Brown, Deborah Money, et al.Pageof 2